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Sunbeds are widely used for cosmetic purposes though disapproved of by dermatologists. A survey from Central Scotland 1 revealed that most users were female and under 35 years of age; 17% had more than 100 sunbed sessions a year.
CASE HISTORY
A woman of 34 was referred to the dermatology department while under psychiatric treatment for bulimia nervosa and alcohol detoxi®cation. She had used sunbeds for up to half an hour three to four times a week over a tenyear period, at cosmetic tanning outlets. During sunny weeks in the UK she would also sunbathe for up to an hour using a protective lotion (SPF 6±8) and she had yearly twoweek holidays to the Mediterranean. As a child she had burned easily but had never blistered. Two years before presentation her skin became dry and itchy and multiple rough lesions began to develop, but she continued to use sunbeds at the same frequency despite noticing two large lesions on her right shin and left breast. There was no family history of skin cancer.
On examination she had a very fair skin with green eyes and auburn hair. Actinic damage was evident on all sunbed exposed skin, comprising multiple irregular lentigines, telangiectasia and dryness (see Figure 1 ). The face also showed premature ageing with forehead, periorbital and perioral furrows and elastosis of the neck. Multiple actinic keratoses were distributed over the whole skin surface except for the axillae and the upper inner thighs. There was a 4 cm 2 exophytic fungating mass on the anterior right mid-shin and a 2 cm 2¯e shy lesion on the upper medial quadrant of the left breast. The lesions were excised and proved on histological examination to be moderately differentiated squamous cell carcinomas (SCCs); three further lesions removed were proliferative bowenoid actinic keratoses.
Xeroderma pigmentosum (XP) and XP variant were excluded when ultraviolet (UV)-irradiated ®broblast cultures from apparently normal skin showed normal DNA repair and normal post-replication repair, respectively. On solar simulator and monochromatic light tests, sensitivity to UV radiation was normal. Since initial presentation, the patient has had multiple SCCs excised and left inguinal node metastasis has been diagnosed. Surgical intervention was complicated by wound dehiscence and infection. She is currently undergoing combination therapy with isotretinoin, interferon a-2a and calcitriol in the hope of delaying disease progression. yet unidenti®ed genetic predisposition to photocarcinogenesis; furthermore, alcohol-induced immunosuppression may have promoted the development of squamous cell carcinoma.
Most¯uorescent-tube sunbeds emit 95% or more UVA with only a small proportion of UVB. The long-term effects of sunbed use in human beings are uncertain because of the delay in development of chronic skin changes, but in hairless mice both UVA and UVB have been shown to induce squamous cell carcinomas 2 . Epidemiological studies suggest an increased risk of malignant melanoma associated with sunbed use, although the evidence is not strong 3 . Nonmelanoma skin cancer following excess sunbed use has been described in a fair-skinned individual with very little exposure to sunlight 4 .
The British Photodermatology Group (BPG) have strongly discouraged the use of sunbeds for cosmetic tanning and recommend that those who persist in using such devices should limit themselves to two courses a year, each of no more than 10 sessions 5 . At present, commercial sunbed exposure is poorly controlled and customers receive inadequate advice and information 6 . Also the use of publicly available sunbeds remains unregulated in the UK. A man of 76 had been receiving treatment for prostate cancer and hypertension. His medication included cyproterone acetate and bendro¯uazide. After the onset of severe uncontrolled urinary frequency and nocturia with incontinence he consulted his general practitioner. No abnormality was found on urine analysis and intranasal desmopressin was prescribed. Two days later he remained thirsty and polyuric, and the general practitioner, suspecting diabetes insipidus, stopped the cyproterone acetate and bendro¯uazide and increased the dose of desmopressin. A renal ultrasound scan was arranged. Three days after the initial presentation his serum sodium was 153 mmol/L (reference range 135±145), potassium 3.1 mmol/L (3.5±5.5), creatinine 212 mmol/L (71±133) and urea 11.0 mmol/L (3.2±7.1). Hospital admission was recommended but the patient refused. Ten days after initial presentation he was still troubled by polyuria and polydipsia. Serum sodium was then 156 mmol/L, potassium 3.7 mmol/L, bicarbonate 32 mmol/L (22±30), chloride 111 mmol/L (98±107), urea 9.5 mmol/L, and creatinine 242 mmol/L and urine osmolality was 282 mosmol/kgÐ i.e. the patient had severe hypernatraemia, renal impairment and a renal concentration defect. An ultrasound scan demonstrated bladder outlet obstruction with bilateral renal hydronephrosis and a distended bladder, although the patient had no sensation of the latter. Two weeks later he underwent transurethral prostatectomy and a suprapubic catheter was inserted. Two weeks postoperatively serum sodium was 142 mmol/L, potassium 5.1 mmol/L, urea 8.1 mmol/L and creatinine 171 mmol/L. Hypernatraemia never recurred. Three months later he was able to go back
